February issue editorial by Thierry Heles, editor
In last month’s editorial, looking back on 2017, this publication noted that university venturing very much appears to be on an upwards trajectory – and if the first few weeks of 2018 are anything to go by, that prediction will more than hold true.
So here are some reasons to be cheerful.
As of the time of writing, our website has just concluded one of the busiest weeks in a while. University of Sydney’s dermatology product spinout Elastagen was acquired…
